Wells Fargo & Company 10x Genomics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,928 shares of TXG stock, worth $186,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,928

Previous 9,732 22.56%

Holding current value

$186,076

Previous $189,000 42.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.71 - $23.49 $34,499 - $51,584	2,196 Added 22.56%	11,928 $269,000
Q2 2024 Aug 13, 2024	SELL	$19.45 - $37.37 $144,377 - $277,397	-7,423 Reduced 43.27%	9,732 $189,000
Q1 2024 May 10, 2024	SELL	$36.08 - $54.3 $343,192 - $516,501	-9,512 Reduced 35.67%	17,155 $643,000
Q4 2023 Feb 09, 2024	SELL	$34.32 - $57.55 $411,462 - $689,966	-11,989 Reduced 31.01%	26,667 $1.49 Million
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $262,688 - $404,898	-6,429 Reduced 14.26%	38,656 $1.59 Million
Q2 2023 Aug 15, 2023	BUY	$50.96 - $58.72 $378,021 - $435,584	7,418 Added 19.69%	45,085 $2.52 Million
Q1 2023 May 12, 2023	SELL	$35.33 - $55.79 $1.18 Million - $1.86 Million	-33,414 Reduced 47.01%	37,667 $2.1 Million
Q4 2022 Feb 13, 2023	SELL	$24.4 - $41.3 $453,132 - $766,982	-18,571 Reduced 20.71%	71,081 $2.59 Million
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $1.12 Million - $2.07 Million	-39,390 Reduced 30.52%	89,652 $2.55 Million
Q2 2022 Aug 12, 2022	SELL	$36.95 - $82.41 $4.38 Million - $9.78 Million	-118,646 Reduced 47.9%	129,042 $5.84 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $3.02 Million - $7.9 Million	54,217 Added 28.02%	247,688 $18.8 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $80.8 Million - $109 Million	-598,229 Reduced 75.56%	193,471 $28.8 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $3.46 Million - $4.56 Million	23,753 Added 3.09%	791,700 $115 Million
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $1.15 Million - $1.74 Million	8,574 Added 1.13%	767,947 $150 Million
Q1 2021 May 13, 2021	BUY	$140.25 - $196.86 $99.1 Million - $139 Million	706,619 Added 1339.46%	759,373 $137 Million
Q4 2020 Feb 09, 2021	BUY	$126.47 - $163.7 $2.44 Million - $3.16 Million	19,293 Added 57.66%	52,754 $7.47 Million
Q3 2020 Nov 05, 2020	SELL	$87.44 - $125.0 $20.1 Million - $28.8 Million	-230,034 Reduced 87.3%	33,461 $4.17 Million
Q2 2020 Aug 13, 2020	SELL	$58.39 - $89.31 $29.9 Million - $45.7 Million	-511,359 Reduced 65.99%	263,495 $23.5 Million
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $40 Million - $82.6 Million	774,854 New	774,854 $48.3 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.48B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company 10x Genomics, Inc. Transaction History